Stockscreener 앱 받기
7.96
1.97%
-0.16
시간 외 거래:
7.96
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Lifecore Biomedical: Inflecting Financials Over Next 3 Years (NASDAQ:LFCR) - Seeking Alpha
Lifecore Signs 10-Year Manufacturing Deal To Support Novel Ophthalmic Therapy - Nasdaq
Lifecore Biomedical Q3 2025 slides: Revenue dip amid ambitious growth strategy By Investing.com - Investing.com South Africa
Lifecore signs 10-year manufacturing deal with key ophthalmic client By Investing.com - Investing.com Nigeria
Lifecore Biomedical Q3 2025 slides: Revenue dip amid ambitious growth strategy - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire
Lifecore Biomedical Enters 10-Year Commercial Manufacturing & Supply Agreement with Existing Customer - Contract Pharma
2025-06-17 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Lifecore signs 10-year manufacturing deal with key ophthalmic client - Investing.com
Lifecore (LFCR) Secures Decade-Long Manufacturing Deal for Ophth - GuruFocus
Lifecore Biomedical Signs 10-Year Manufacturing, Supply Deal With Ophthalmic Therapy Customer - MarketScreener
Lifecore (LFCR) Secures Decade-Long Manufacturing Deal for Ophthalmic Therapy | LFCR Stock News - GuruFocus
Lifecore Biomedical Signs 10-Year Commercial Manufacturing Agreement to Advance Novel Ophthalmic Therapeutic - Nasdaq
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer - GlobeNewswire
Lifecore Biomedical Lands Multi-Million Dollar, 10-Year Manufacturing Contract for Novel Eye Treatment - Stock Titan
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Bank of America Corp DE - Defense World
Lifecore Biomedical receives accelerated payment of remaining $10M in proceeds from equipment sale - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Lifecore receives early $10 million payment for equipment sale By Investing.com - Investing.com South Africa
Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale - GlobeNewswire
Lifecore Receives Full Payment Early For $17 Mln Equipment Sale - Nasdaq
Lifecore Biomedical Receives Remaining $10 Million for Sale of Isolator Filler Ahead of Schedule - marketscreener.com
Lifecore (LFCR) Completes $10 Million Equipment Sale Payment | LFCR Stock News - GuruFocus
Lifecore receives early $10 million payment for equipment sale - Investing.com Australia
Lifecore Biomedical Fast-Tracks $10M Equipment Payment as New Filler Promises $300M Revenue Potential - Stock Titan
2025-06-10 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Squarepoint Ops LLC Reduces Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
(LFCR) Long Term Investment Analysis - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Deutsche Bank AG Reduces Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Contrasting Lifecore Biomedical (NASDAQ:LFCR) & Liquidia (NASDAQ:LQDA) - Defense World
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by BNP Paribas Financial Markets - Defense World
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical (NASDAQ:LFCR) shareholders have endured a 37% loss from investing in the stock five years ago - Yahoo Finance
How the (LFCR) price action is used to our Advantage - news.stocktradersdaily.com
Lifecore appoints new chief commercial officer to drive growth By Investing.com - Investing.com South Africa
Lifecore Biomedical Appoints CCO - Contract Pharma
Lifecore Biomedical Names Mark Dafonseca Chief Commercial Officer - marketscreener.com
LFCR Appoints New Chief Commercial Officer | LFCR Stock News - GuruFocus
Lifecore appoints new chief commercial officer to drive growth - Investing.com
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer - GlobeNewswire
Lifecore Biomedical Taps 30-Year Pharma Veteran as CCO to Accelerate CDMO Market Expansion - Stock Titan
Northern Trust Corp Purchases 28,019 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Analysts Set Expectations for LFCR Q4 Earnings - Defense World
William Blair Begins Coverage on Lifecore Biomedical (NASDAQ:LFCR) - Defense World
What Makes Lifecore Biomedical (LFCR) a Beneficiary of the Trade Policies? - Insider Monkey
Lifecore Biomedical (LFCR) Receives 'Outperform' Rating from Wil - GuruFocus
Lifecore stock gains on Outperform rating by William Blair - Investing.com Canada
William Blair Initiates Coverage on Lifecore Biomedical With Outperform Rating - marketscreener.com
Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings - Seeking Alpha
Barclays PLC Buys 4,028 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Wells Fargo & Company MN Has $99,000 Stock Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) hedge funds shareholders had a great week as one-year returns increased after a 11% gain last week - Yahoo Finance
A Piece Of The Puzzle Missing From Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Share Price - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
1.05%
0.60%
자본화:
|
볼륨(24시간):